This stack builds on foundational regenerative compounds with the addition of a copper-binding peptide commonly studied in advanced research settings
Thus, todays supplement formulas can reach brain cells, and other cells outside the GI tract, so IV glutathione might not be necessary
Experimentally, this relationship has been verified in breast cancer patients with an r 2 of 0.6262 [30], supporting its use as a surrogate marker of low global GSH states in general
[DOI] [PMC free article] [PubMed] [Google Scholar] 102.Rasic D., Zenko Sever A., Rasic F., Strbe S., Rasic Z., Djuzel A., Duplancic B., Boban Blagaic A., Skrtic A., Seiwerth S., et al
[DOI] [PubMed] [Google Scholar] 8.Raju KS, Alessandri G, Gullino PM
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
